InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.09
(
0.75%
)
US TECH 100
18,319.60
(
0.95%
)
Dow Jones
39,161.70
(
0.25%
)
Brent Oil
82.06
(
0.92%
)
Bitcoin
68,575.57
(
0.96%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: Jesspro post# 49957

Monday, 06/09/2014 1:58:26 PM

Monday, June 09, 2014 1:58:26 PM

Post# of 80490
Denner of course understands that the IDIX windfall for his investment group was a result of a bidding war (in which I assume he played a role).


"Biotech this morning is doing well due to Merck's (NYSE:MRK) bid for Idenix Pharmaceuticals (NASDAQ:IDIX) for a hefty premium in a competitive bidding war against (apparently) Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV). Idenix closed at $7.23 on Friday and was bought for $24."

http://www.minyanville.com/special-features/from-the-buzz-banter/articles/Negative-Sentiment-Nearly-Unanimous-Among/6/9/2014/id/55241
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up